Patent details

EP2970290 Title: A CRYSTALLINE FORM OF AN ANXIOLYTIC COMPOUND

Basic Information

Publication number:
EP2970290
PCT Application Number:
AU2013000497
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138782206
PCT Publication Number:
WO2014138772
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A CRYSTALLINE FORM OF AN ANXIOLYTIC COMPOUND
French Title of Invention:
FORME CRISTALLINE D'UN COMPOSÉ ANXIOLYTIQUE
German Title of Invention:
KRISTALLINE FORM EINER ANGSTLÖSENDEN VERBINDUNG
SPC Number:

Dates

Filing date:
14/05/2013
Grant date:
22/07/2020
EP Publication Date:
20/01/2016
PCT Publication Date:
18/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/07/2020
EP B1 Publication Date:
22/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/05/2021
Expiration date:
14/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/07/2020
 
 

Name:
Bionomics Limited
Address:
31 Dalgleish Street, Thebarton, South Australia 5031, Australia (AU)

Inventor

1

Name:
PAUL, Dharam
Address:
Australia (AU)

2

Name:
HARVEY, Andrew John
Address:
Australia (AU)

3

Name:
FLYNN, Bernard Luke
Address:
Australia (AU)

Priority

1

Priority Number:
201361787436 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

2

Priority Number:
2013204159
Priority Date:
12/04/2013
Priority Country:
Australia (AU)

Classification

IPC classification:
A61K 31/4375; A61P 25/16; A61P 25/22; A61P 25/24; A61P 25/28; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
202030
Publication date:
22/07/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages